After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Biotech stocks remain pressured following the recent Brexit vote, which will make investing in these already highly volatile stocks even trickier. But there are opportunities too.
Trade-Ideas LLC identified Array BioPharma (ARRY) as a weak on high relative volume candidate
Six patients, all with TRK fusion cancers unresponsive to current therapies, reported tumor shrinkage following treatment with Loxo's drug LOXO-101.
Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.